{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:18:12Z","timestamp":1793927892021,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1038\/s41440-018-0186-2","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T08:11:35Z","timestamp":1546589495000},"page":"761-768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["The pivotal role of melatonin in ameliorating chronic kidney disease by suppression of the renin\u2013angiotensin system in the kidney"],"prefix":"10.1038","volume":"42","author":[{"given":"Naro","family":"Ohashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"186_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1056\/NEJM199701163360306","volume":"336","author":"A Brzezinski","year":"1997","unstructured":"Brzezinski A. Melatonin in humans. N Engl J Med. 1997;336:186\u201395.","journal-title":"N Engl J Med"},{"key":"186_CR2","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.2741\/4075","volume":"17","author":"M Russcher","year":"2012","unstructured":"Russcher M, Koch B, Nagtegaal E, van der Putten K, ter Wee P, Gaillard C. The role of melatonin treatment in chronic kidney disease. Front Biosci. 2012;17:2644\u201356.","journal-title":"Front Biosci"},{"key":"186_CR3","first-page":"577","volume":"7","author":"E Grossman","year":"2011","unstructured":"Grossman E, Laudon M, Zisapel N. Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials. Vasc Health Risk Manag. 2011;7:577\u201384.","journal-title":"Vasc Health Risk Manag"},{"key":"186_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/ndt\/gfp493","volume":"25","author":"BC Koch","year":"2010","unstructured":"Koch BC, van der Putten K, Van Someren EJ, Wielders JP, Ter Wee PM, Nagtegaal JE, et al. Impairment of endogenous melatonin rhythm is related to the degree of chronic kidney disease (CREAM study). Nephrol Dial Transplant. 2010;25:513\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"186_CR5","doi-asserted-by":"publisher","first-page":"F336","DOI":"10.1152\/ajprenal.00500.2007","volume":"294","author":"Y Quiroz","year":"2008","unstructured":"Quiroz Y, Ferrebuz A, Romero F, Vaziri ND, Rodriguez-Iturbe B. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in renal mass reduction. Am J Physiol Ren Physiol. 2008;294:F336\u201344.","journal-title":"Am J Physiol Ren Physiol"},{"key":"186_CR6","doi-asserted-by":"publisher","first-page":"e97713","DOI":"10.1371\/journal.pone.0097713","volume":"9","author":"BM Escribano","year":"2014","unstructured":"Escribano BM, Moreno A, Tasset I, Tunez I. Impact of light\/dark cycle patterns on oxidative stress in an adriamycin-induced nephropathy model in rats. PLoS ONE. 2014;9:e97713.","journal-title":"PLoS ONE"},{"key":"186_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/hr.2016.103","volume":"40","author":"C Agabiti-Rosei","year":"2017","unstructured":"Agabiti-Rosei C, Favero G, De Ciuceis C, Rossini C, Porteri E, Rodella LF, et al. Effect of long-term treatment with melatonin on vascular markers of oxidative stress\/inflammation and on the anticontractile activity of perivascular fat in aging mice. Hypertens Res. 2017;40:41\u201350.","journal-title":"Hypertens Res"},{"key":"186_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/pr.59.3.3","volume":"59","author":"H Kobori","year":"2007","unstructured":"Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251\u201387.","journal-title":"Pharmacol Rev"},{"key":"186_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/hy0202.103821","volume":"39","author":"LG Navar","year":"2002","unstructured":"Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension. 2002;39:316\u201322.","journal-title":"Hypertension"},{"key":"186_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bbrc.2007.04.105","volume":"22","author":"H Kobori","year":"2007","unstructured":"Kobori H, Katsurada A, Ozawa Y, Satou R, Miyata K, Hase N, et al. Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. Biochem Biophys Res Commun. 2007;22:156\u201363.","journal-title":"Biochem Biophys Res Commun"},{"key":"186_CR11","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1681\/ASN.2006060554","volume":"18","author":"T Yamamoto","year":"2007","unstructured":"Yamamoto T, Nakagawa T, Suzuki H, Ohashi N, Fukasawa H, Fujigaki Y, et al. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol. 2007;18:1558\u201365.","journal-title":"J Am Soc Nephrol"},{"key":"186_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jash.2008.04.008","volume":"2","author":"H Kobori","year":"2008","unstructured":"Kobori H, Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, et al. Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens. 2008;2:349\u201354.","journal-title":"J Am Soc Hypertens"},{"key":"186_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1161\/HYPERTENSIONAHA.108.123802","volume":"53","author":"H Kobori","year":"2009","unstructured":"Kobori H, Alper AB Jr, Shenava R, Katsurada A, Saito T, Ohashi N, et al. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension. 2009;53:344\u201350.","journal-title":"Hypertension"},{"key":"186_CR14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/MAJ.0b013e3181b90c25","volume":"338","author":"T Saito","year":"2009","unstructured":"Saito T, Urushihara M, Kotani Y, Kagami S, Kobori H. Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci. 2009;338:478\u201380.","journal-title":"Am J Med Sci"},{"key":"186_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/ndt\/gfq371","volume":"26","author":"A Nishiyama","year":"2011","unstructured":"Nishiyama A, Konishi Y, Ohashi N, Morikawa T, Urushihara M, Maeda I, et al. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26:170\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"186_CR16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/01.HYP.0000056768.03657.B4","volume":"41","author":"H Kobori","year":"2003","unstructured":"Kobori H, Nishiyama A, Abe Y, Navar LG. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension. 2003;41:592\u20137.","journal-title":"Hypertension"},{"key":"186_CR17","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1161\/01.HYP.0000122875.91100.28","volume":"43","author":"H Kobori","year":"2004","unstructured":"Kobori H, Prieto-Carrasquero MC, Ozawa Y, Navar LG. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension. 2004;43:1126\u201332.","journal-title":"Hypertension"},{"key":"186_CR18","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1681\/ASN.2004080676","volume":"16","author":"H Kobori","year":"2005","unstructured":"Kobori H, Ozawa Y, Suzaki Y, Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol. 2005;16:2073\u201380.","journal-title":"J Am Soc Nephrol"},{"key":"186_CR19","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1440-1681.2008.04938.x","volume":"35","author":"K Miyata","year":"2008","unstructured":"Miyata K, Ohashi N, Suzaki Y, Katsurada A, Kobori H. Sequential activation of the reactive oxygen species\/angiotensinogen\/renin-angiotensin system axis in renal injury of type 2 diabetic rats. Clin Exp Pharmacol Physiol. 2008;35:922\u20137.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"186_CR20","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1440-1681.2009.05172.x","volume":"36","author":"N Ohashi","year":"2009","unstructured":"Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Urushihara M, et al. Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol. 2009;36:750\u20135.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"186_CR21","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/HYPERTENSIONAHA.110.165704","volume":"57","author":"M Urushihara","year":"2011","unstructured":"Urushihara M, Ohashi N, Miyata K, Satou R, Acres OW, Kobori H. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis. Hypertension. 2011;57:586\u201393.","journal-title":"Hypertension"},{"key":"186_CR22","doi-asserted-by":"publisher","first-page":"F1512","DOI":"10.1152\/ajprenal.00058.2008","volume":"295","author":"N Ohashi","year":"2008","unstructured":"Ohashi N, Yamamoto T, Huang Y, Misaki T, Fukasawa H, Suzuki H, et al. Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats. Am J Physiol Ren Physiol. 2008;295:F1512\u20138.","journal-title":"Am J Physiol Ren Physiol"},{"key":"186_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/hr.2015.151","volume":"39","author":"S Isobe","year":"2016","unstructured":"Isobe S, Ohashi N, Ishigaki S, Tsuji T, Sakao Y, Kato A, et al. Augmented circadian rhythm of the intrarenal renin-angiotensin systems in anti-thymocyte serum nephritis rats. Hypertens Res. 2016;39:312\u201320.","journal-title":"Hypertens Res"},{"key":"186_CR24","doi-asserted-by":"publisher","first-page":"23045","DOI":"10.3390\/ijms141123045","volume":"14","author":"M Kamiyama","year":"2013","unstructured":"Kamiyama M, Urushihara M, Morikawa T, Konishi Y, Imanishi M, Nishiyama A, et al. Oxidative stress\/angiotensinogen\/renin-angiotensin system axis in patients with diabetic nephropathy. Int J Mol Sci. 2013;14:23045\u201362.","journal-title":"Int J Mol Sci"},{"key":"186_CR25","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.bbrc.2004.01.120","volume":"315","author":"H Kobori","year":"2004","unstructured":"Kobori H, Nishiyama A. Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. Biochem Biophys Res Commun. 2004;315:746\u201350.","journal-title":"Biochem Biophys Res Commun"},{"key":"186_CR26","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1016\/0006-2952(86)90048-1","volume":"35","author":"T Souchet","year":"1986","unstructured":"Souchet T, Br\u00e9e F, Baatard R, Fontenaille C, D\u2019Athis P, Tillement JP, et al. Impaired regulation of beta 2-adrenergic receptor density in mononuclear cells during chronic renal failure. Biochem Pharmacol. 1986;35:2513\u20139.","journal-title":"Biochem Pharmacol"},{"key":"186_CR27","unstructured":"Nagtegaal JE, Smits MG, Kerkhof GA, Pandi-Perumal SR. Chronobiological, clinical and pharmacological aspects of melatonin in human circadian rhythm dysfunction. In: Haldar C, Singaravel M, Kumar Maitra S, editors. Treatise on pineal gland and melatonin. Enfield: Science Publishers; 2002. p. 461\u201389."},{"key":"186_CR28","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1089\/end.2009.0035","volume":"23","author":"E Ozbek","year":"2009","unstructured":"Ozbek E, Ilbey Y, Ozbek M, Simsek A, Cekmen M, Somay A. Melatonin attenuates unilateral ureteral obstruction-induced renal injury by reducing oxidative stress, iNOS, MAPK, and NF-kB expression. J Endourol. 2009;23:1165\u201373.","journal-title":"J Endourol"},{"key":"186_CR29","doi-asserted-by":"publisher","first-page":"F447","DOI":"10.1152\/ajprenal.00264.2002","volume":"284","author":"M Nava","year":"2003","unstructured":"Nava M, Quiroz Y, Vaziri N, Rodriguez-Iturbe B. Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Ren Physiol. 2003;284:F447\u201354.","journal-title":"Am J Physiol Ren Physiol"},{"key":"186_CR30","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296\u2013305.","journal-title":"N Engl J Med"},{"key":"186_CR31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0272-6386(03)00916-8","volume":"42","author":"N Drey","year":"2003","unstructured":"Drey N, Roderick P, Mullee M, Rogerson M. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis. 2003;42:677\u201384.","journal-title":"Am J Kidney Dis"},{"key":"186_CR32","unstructured":"Renal Data System. USRDS 2003 annual data report: atlas of end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2003."},{"key":"186_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10157-009-0199-x","volume":"13","author":"E Imai","year":"2009","unstructured":"Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621\u201330.","journal-title":"Clin Exp Nephrol"},{"key":"186_CR34","first-page":"251","volume":"38","author":"D Acu\u00f1a","year":"1982","unstructured":"Acu\u00f1a D, Soler A, Garc\u00eda-Torres L, Vargas F, Garc\u00eda del R\u00edo C, Quesada T, et al. Inhibition of the renin-angiotensin system by pinealectomy in female rats. Rev Esp Fisiol. 1982;38:251\u20135.","journal-title":"Rev Esp Fisiol"},{"key":"186_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0169-328X(97)00339-2","volume":"54","author":"O Baltatu","year":"1998","unstructured":"Baltatu O, Lippoldt A, Hansson A, Ganten D, Bader M. Local renin-angiotensin system in the pineal gland. Brain Res Mol Brain Res. 1998;54:237\u201342.","journal-title":"Brain Res Mol Brain Res"},{"key":"186_CR36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1046\/j.0022-3042.2001.00701.x","volume":"80","author":"O Baltatu","year":"2002","unstructured":"Baltatu O, Afeche SC, Jos\u00e9 dos Santos SH, Campos LA, Barbosa R, Michelini LC, et al. Locally synthesized angiotensin modulates pineal melatonin generation. J Neurochem. 2002;80:328\u201334.","journal-title":"J Neurochem"},{"key":"186_CR37","doi-asserted-by":"publisher","first-page":"521783","DOI":"10.1155\/2013\/521783","volume":"2013","author":"LA Campos","year":"2013","unstructured":"Campos LA, Cipolla-Neto J, Amaral FG, Michelini LC, Bader M, Baltatu OC. The angiotensin-melatonin axis. Int J Hypertens. 2013;2013:521783.","journal-title":"Int J Hypertens"},{"key":"186_CR38","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s10157-015-1224-x","volume":"20","author":"S Ishigaki","year":"2016","unstructured":"Ishigaki S, Ohashi N, Isobe S, Tsuji N, Iwakura T, Ono M, et al. Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease. Clin Exp Nephrol. 2016;20:878\u201384.","journal-title":"Clin Exp Nephrol"},{"key":"186_CR39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10157-017-1505-7","volume":"22","author":"S Ishigaki","year":"2018","unstructured":"Ishigaki S, Ohashi N, Matsuyama T, Isobe S, Tsuji N, Iwakura T, et al. Melatonin ameliorates intrarenal renin-angiotensin system in a 5\/6 nephrectomy rat model. Clin Exp Nephrol. 2018;22:539\u201349.","journal-title":"Clin Exp Nephrol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0186-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0186-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0186-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:20:10Z","timestamp":1684617610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-018-0186-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["186"],"URL":"https:\/\/doi.org\/10.1038\/s41440-018-0186-2","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}